Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank

INTRODUCTION: Cord blood (CB) is considered a human cell, tissue, and cellular-based product (HCT/P) by the U.S. Food and Drug Administration (FDA) and is licensed through a Biological Licensing Application (BLA). Cord blood units (CBUs) require less precise donor tissue matching than other stem cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Guggenheim, Dana S, Kurtzberg, Joanne, Shaz, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cord Blood Bank Management, Administration, and Sustainability
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446955/
http://dx.doi.org/10.1093/stcltm/szac057.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446955/
http://dx.doi.org/10.1093/stcltm/szac057.027

Ejemplares similares